Cancel
OK

You have successfully logged out.

Hello !
chevron_right My profile
chevron_right To My B. Braun overview
Logout

No content results match your keyword.

Content

    No product results match your keyword.

    Products

      Neurosurgery

      Hydrocephalus & ICP management

      Gravitational valves improve patient outcomes

      Hydrocephalus shunts, intraventricular neuroendoscopy and long-term implants for non-invasive telemetric pressure measurement

      In the treatment of hydrocephalus, so-called shunt systems are very often implanted in order to drain the excess cerebrospinal fluid (CSF) to other parts of the body. This is done in an attempt to bring the intracranial pressure, which is elevated due to the accumulation of fluid in the brain, back into the normal range in order to prevent damage to the brain.

      An alternative procedure to shunt surgery is an endoscopic third ventriculostomy (ETV). Instead of inserting a shunt, the surgeon makes a hole in the floor of third ventricle to allow the trapped cerebrospinal fluid (CSF) to escape to the brain's surface, where it can be absorbed. Aesculap offers various intraventricular neuroendoscopic systems: MINOP®, PaediScope® and MINOP® InVent.

      MIETHKE gravitational shunts offer special protection to avoid position-dependent complications such as over- and underdrainage, with positive clinical outcomes for the patient and a significant reduction of overdrainage events. [1-4]

      All MIETHKE valves are manufactured with high precision from titanium and are protected against unintentional reprogramming by magnetic fields of up to 3 Tesla.5

      Advances in shunt technology, in particular adjustable and gravitational valves, have improved patient outcomes.6-7 Finding the best possible patient-individual pressure setting and assessing shunt function can however be challenging and time-consuming. M.scio® is a telemetric pressure sensor approved for permanent implantation. Valve adjustments following telemetric read-out of the pressure via the M.scio® improve outcomes in most patients and knowledge of the pressure can help to avoid unnecessary hospitalizations, investigations, and radiation exposure. 6-8

      Hydrocephalus & ICP Management
      Related information

      Related products

      Digital applications

      MIETHKE HC&ME App – Patient diary app

      iTunes preview and free download >>
      Google Play preview and free download >>

      MIETHKE App – Understanding valves easily

      iTunes preview and free download >>
      Google Play preview and free download >>

      THOMALE GUIDE App – An accessory for the THOMALE GUIDE

      iTunes preview and free download >>

      Get in touch with our experts

      The protection of the personal data of our customers is very important to us and we take it very seriously. Your personal data is subject to data protection and will only be collected and stored for approach reasons. Under no circumstances will we pass on your personal data to third parties outside of the B. Braun group or use or store them for any other purposes. Our staff has been trained to handle personal data and is obliged to comply with the data protection regulations.

      Thank you very much for your request!

      check_circle

      It will be forwarded to a responsible contact person who will get in touch with you as soon as possible.

      Your request could not be submitted. Please try again.

      warning

      References

      1. Tschan CA, Antes S, Huthmann A, et al. Overcoming CSF overdrainage with the adjustable gravitational valve proSA. Acta Neurochir (Wien). 2014;156(4):767-76; discussion 776.

      2. Suchorska B, Kunz M, Schniepp R, et al. Optimized surgical treatment for normal pressure hydrocephalus: comparison between gravitational and differential pressure valves. Acta Neurochir (Wien). 2015;157(4):703-9.

      3. Lemcke J, Meier U, Muller C, et al. Safety and efficacy of gravitational shunt valves in patients with idiopathic normal pressure hydrocephalus: a pragmatic, randomised, open label, multicentre trial (SVASONA). J Neurol Neurosurg Psychiatry. 2013;84(8):850-7

      4. Sprung C, Schlosser HG, Lemcke J, et al. The adjustable proGAV shunt: a prospective safety and reliability multicenter study. Neurosurgery. 2010;66(3):465-74.

      5. Chari A, Czosnyka M, Richards HK, Pickard JD, Czosnyka ZH. Hydrocephalus shunt technology: 20 years of experience from the Cambridge Shunt Evaluation Laboratory. J Neurosurg. 2014;120(3):697-707.

      6.Antes S, Stadie A, Muller S, et al. Intracranial Pressure-Guided Shunt Valve Adjustments with the Miethke Sensor Reservoir. World Neurosurg. 2018;109:e642-e50.

      7. Freimann FB, Schulz M, Haberl H, et al. Feasibility of telemetric ICP-guided valve adjustments for complex shunt therapy. Childs Nerv Syst. 2014;30(4):689-97.

      8. Thompson S, Thorne L, Toma A, et al. Telemetric monitoring of ICP within a shunt system. A single centre experience including the first in vivo comparison versus conventional intraparenchymal monitoring. Fluids and Barriers of the CNS. 2017;14(Suppl 1):A63.

      We use cookies to enable all functionalities for best performance during your visit and to improve our services by giving us some insight into how the website is being used. Continued use of our website without having changed your browser settings confirms your acceptance of these cookies. For details please see our

      privacy policy.